Immunocore Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	467.71	455.73	442.63	402.47	321.62
Short-Term Investments	396.44	364.65	-	-	-
Cash & Short-Term Investments	864.15	820.38	442.63	402.47	321.62
Cash Growth	5.34%	85.34%	9.98%	25.14%	81.35%
Accounts Receivable	198.49	166.26	133.39	33.58	20.56
Other Receivables	1.82	-	0.76	-	13.02
Total Trade Receivables	200.3	166.26	134.16	33.58	33.58
Inventory	6.74	5.45	4.5	0.69	-
Other Current Assets	50.06	41.03	29.6	37.23	-
Total Current Assets	996.74	929.86	528.82	473.98	355.2
Net Property, Plant & Equipment	99.59	93.38	84.14	38.78	42.64
Other Intangible Assets	-	-	2.02	-	-
Other Long-Term Assets	40.56	66.01	53.38	14.01	10.15
Total Assets	2,134	2,010	1,198	526.76	408
Accounts Payable	268.91	235.05	153.83	14.45	-
Accrued Expenses	219.74	185.53	119.84	76.75	-
Current Portion of Long-Term Debt	-	-	1.11	-	-
Current Portion of Leases	5.23	3.17	2.78	1.88	1.7
Unearned Revenue	0.58	-	-	7.76	33.06
Other Current Liabilities	0.06	-	0.06	-	-
Total Current Liabilities	495.11	423.75	277.61	100.84	34.75
Long-Term Debt	737.96	724	94.98	47.81	50.33
Long-Term Leases	84.91	81.59	72.73	31.76	34.28
Other Long-Term Liabilities	10.38	11.52	12.55	7.46	8.66
Total Long-Term Liabilities	393.71	380.5	90.14	87.02	93.27
Total Liabilities	1,328	1,241	456.89	187.86	176.07
Common Stock	0.27	0.26	0.26	0.13	0.12
Additional Paid-in Capital	2,059	1,618	1,480	1,083	-
Accumulated Other Comprehensive Income	432	395.41	390.93	-54.67	-
Retained Earnings	-1,685	-1,245	-1,130	-689.39	-650.84
Shareholders' Equity	805.76	769.13	741.08	338.9	231.93
Total Liabilities & Equity	2,134	2,010	1,198	526.76	408
Total Debt	828.09	808.76	171.6	81.45	86.31
Net Cash (Debt)	36.06	11.61	271.03	321.02	235.31
Net Cash Growth	210.53%	-95.71%	-15.57%	36.42%	161.46%
Net Cash Per Share	0.72	0.23	5.54	7.02	5.54
Book Value	805.76	769.13	741.08	338.9	231.93
Book Value Per Share	16.00	15.39	15.16	7.41	5.46
Tangible Book Value	805.76	769.13	739.05	338.9	231.93
Tangible Book Value Per Share	16.00	15.39	15.12	7.41	5.46

Updated Feb 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q